Dr. Jules Bayliss

Dr. Jules Bayliss is the leader of the antivenom development team at CSL Seqirus, where she oversees the complex process of creating antivenoms from the venom of various Australian snakes and spiders. With a focus on public health, she ensures that antivenoms are distributed effectively to areas most at risk for snake and spider bites, both in Australia and in neighboring Papua New Guinea. Her work is instrumental in saving lives and reducing the incidence of venomous bites through the development and supply of effective treatments.